Kane Biotech Inc. (KNBIF)
OTCMKTS
· Delayed Price · Currency is USD
0.0371
0.00 (0.00%)
Jun 11, 2025, 8:00 PM EDT
Kane Biotech Revenue
Kane Biotech had revenue of 412.51K CAD in the quarter ending March 31, 2025, with 695.04% growth. This brings the company's revenue in the last twelve months to 2.44M, up 1,374.38% year-over-year. In the year 2024, Kane Biotech had annual revenue of 2.08M with 1,296.75% growth.
Revenue (ttm)
2.44M CAD
Revenue Growth
+1,374.38%
P/S Ratio
4.31
Revenue / Employee
n/a
Employees
n/a
Market Cap
7.33M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.08M | 1.93M | 1,296.75% |
Dec 31, 2023 | 148.98K | -7.75K | -4.95% |
Dec 31, 2022 | 156.73K | -1.45M | -90.25% |
Dec 31, 2021 | 1.61M | 266.20K | 19.84% |
Dec 31, 2020 | 1.34M | -351.95K | -20.78% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |
Kane Biotech News
- 14 days ago - Kane Biotech reports Q1 results - Seeking Alpha
- 15 days ago - Kane Biotech Announces First Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Philip Renaud files Early Warning Report in respect of Kane Biotech Inc. - Benzinga
- 5 weeks ago - Kane Biotech Announces Closing of Private Placement Offering and Loan with Insiders of the Company - GlobeNewsWire
- 6 weeks ago - Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change - Benzinga
- 6 weeks ago - Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change - GlobeNewsWire
- 2 months ago - Kane Biotech Announces New Agreement with Outside the Box Capital Inc. - GlobeNewsWire
- 3 months ago - Kane Biotech Secures IRB Approval to Launch Innovative DispersinB® Acne Trial - GlobeNewsWire